Serotonin signalling in the gutfunctions, dysfunctions and therapeutic targets
While a minor difference in gum color is typical, a substantial shift might indicate an underlying health concern
Whenever we have a new medicine, we always restart the clock in terms of safety. In a response to Scientific American s request for comment, the Eli Lilly spokesperson said that the FDA reviewed the companys robust clinical data package and that the approval establishes Foundayos strong safety and efficacy profile. Foundayo and other weight-loss drug candidates in the works could increase supply and help with affordability of GLP-1 drugs overallthough that might take some time, Horn says
The difference between the pooled BMT doses and placebo was statistically significant, indicating that women treated with higher doses of BMT experienced a notable increase in sexual satisfaction compared to those on placebo
Never discontinue therapy without medical guidance, as abrupt cessation can affect glycemic control in diabetes patients
Based on currently available data, no further assessment of CV outcomes of dulaglutide and liraglutide is being carried out